Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: A comparison with other populations

Leukemia Research

Volumn 32, Issue 12, 2008, Pages 1824-1829

  Gmidène, Abir ^a   Sennana, Hlima ^a   Fenaux, Pierre ^b   Laatiri, Adnène ^a   Zarrouk, Mohamed ^c   Bouaziz, Houssem ^d   Harrabi, Imed ^a   Saad, Ali ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b AVICENNE HOSPITAL   (France)

^c Hopital Aziza Othmana   (Tunisia)

^d HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Chromosomal abnormalities; Cytogenetics; FAB subgroups; IPSS risk groups; Myelodysolastic syndromes; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; EUROPE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; POPULATION; PRIORITY JOURNAL; RISK FACTOR; TUNISIA;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DOWN SYNDROME; FRANCE; GREAT BRITAIN; HUMANS; KARYOTYPING; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK ASSESSMENT; SEQUENCE DELETION; TRISOMY; TUNISIA; UNITED STATES;

EID: 51849109006     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.05.002     Document Type: Article

References (33)

1. Fenaux P., Morel P., and Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin Hematol 33 (1996) 127-138
2. Heaney M.L., and Golde D.W. Myelodysplasia. N Eng J Med 340 (1999) 1649-1660
3. Germing U., Gattermann N., Shopp C., Aivado M., and Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24 (2000) 983-992
4. Goasguen J.E., and Bennett J.M. Classification and morphologic features of myelodysplastic syndromes. Semin Oncol 19 (1992) 4-13
5. Howe R.B., and Porwit-MacDonald A.P. The WHO classification of MDS does make a difference. Blood 103 (2004) 3265-3270
6. Raynaud S.D. Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes. Pathol Biol 5 (2003) 346-355
7. Greenberg P., Cox C., Le Beau M., Fenaux P., Morel P., and Sanz G. International scoring system of evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
8. ISCN. In: Mitelman F. (Ed). An international system for human cytogenetic nomenclature (2005), S. Karger, Basel, Switzerland
9. Matsuda A., Germing U., Jinnai I., Misumi M., Kuendgen A., Knipp S., et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Clin Trial Obs 106 (2005) 2633-2640
10. Lee D.S., Kim S.H., Seo E.J., Park C.J., Chi H.S., Ko E.K., et al. Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet 132 (2002) 97-101
11. Irons R.D., Wang X., Gross S.A., Bao L., Ryder J., Chen Y., et al. Prevalence of MDS subtypes in shanghai, China: a comparison of the World Health Organization and French American British classifications. Leuk Res 30 (2006) 769-775
12. Chen B., Zhao W.L., Jlin J., Xue Y.Q., Cheng X., Chen X.T., et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19 (1995) 767-775
13. Toyoma K., Ohyashiki K., and Yashida Y. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicenter study in Japan. Leukemia 7 (1993) 499-508
14. Komorkji R. Myelodysplastic syndromes: a view where the sun rises and where the sun sets. Leuk Res 30 (2006) 1067-1068
15. Haase D., Steidl C., Schanz J., Schabla R., Pfeilstöcker M., Nösslinger T., et al. Correlation of cytogentic findings with morphology, clinical courses and prognosis in 2124 patients with MDS. Blood 106 (2005) 787
16. Solé F., Prieto F., Badia L., Waessner S., Floensa L., Caballin M.R., et al. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 64 (1992) 12-20
17. Panani A.D., and Roussos C. Cytogenetic aspects of adult primary myelodysplastic syndromes clinical implications. Cancer Lett 235 (2006) 177-190
18. Aktas D., and Tuncbilek E. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study. Cancer Genet Cytogenet 171 (2006) 72-75
19. Mhawech P., and Saleem A. Myelodysplastic syndrome: review of cytogenetic and molecular data. Crit Rev Oncol Hematol 40 (2001) 229-238
20. Lessard M., Helias C., Struski S., Perrusson N., Uetwiller F., Mozziconacci M.J., et al., on behalf of the Groupe Francophone de Cytogénétique Hématologique (GFCH). Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukaemia actually differ?. Cancer Genet Cytogenet 176 (2007) 1-21
21. Matsushima T., Handa H., Yokohama A., Nagasaki J., Koiso H., Kin Y., et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. Blood 101 (2003) 3386-3390
22. Look T.A. Molecular pathogenesis of MDS. Hematology (2005) 156-160
23. United Kingdom Cancer Cytogenetics Group (UKCCG). Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer 5 (1992) 83-88
24. Wiktor A., Rybicki A., Pios S., Shurafa M., Barthel B., Maeda K., et al. Clinical significance of Y chromosome loss in haematological disease. Genes Chromosomes Cancer 27 (2000) 11-16
25. Babicka L., Ransdorfova S., Brezinova J., Zemanova Z., Sindelarova L., Siskova M., et al. Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH. Leuk Res 31 (2007) 39-47
26. Solé F., Espinet B., Sanz F., Cervera J., Calasanz M.J., Luna E., et al. Incidence characterisation and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol (2000) 346-356
27. Elghetany M.T. Myelodysplastic syndromes in children. A critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Arch Pathol Lab Med 131 (2007) 1110-1116
28. Chatterjee T., Mahapatra M., Dixit A., Naithani S., Tyagi S., Mishra P., et al. Primary myelodysplastic syndrome in children-clinical, haematological and histomorphological profile from a tertiary care centre in India. Hematology 10 (2005) 495-499
29. Parlier V., Van Melle G., Beris P., Schmidt P.M., Tobler A., and Bellomo M.J. Hematologic, clinical and cytogenetic ananlysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings. Cancer Genet Cytogenet 78 (1994) 219-231
30. Pierre R.V., Catovsky D., Mufti G.J., Mecucci C., Dewald G.W., Rutu T., et al. Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet 40 (1989) 149-161
31. Borgonovo T., Ribeiro E.M.S.F., Cornélio D.A., Schmid-Braz A.T., Jamur V.R., Wuicik L., et al. Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS). Genet Mol Biol 28 (2005) 18-30
32. Ma X., Does M., Raza A., and Mayne S.T. Myelodysplastic syndromes: incidence and survival in the united states. Cancer 109 (2007) 1536-1542
33. Jacobs R.H., Combleet M.A., Vardiman J.W., Larson R.A., Le Beau M.M., and Rowley J.D. Prognostic implications of morphology and karyotype in primary myelodysplastiques syndromes. Blood 67 (1986) 1765-1772